Biocogniv Competitor Insights

Biocogniv is an AI-driven diagnostics company focused on improving patient outcomes in acute care settings. They develop and deploy AI-based diagnostic tools that leverage routine blood tests to detect and predict acute conditions, such as sepsis, before they become irreversible. Their flagship product, Sepsis aiMarker™, has received FDA Breakthrough Designation and can predict sepsis up to 72 hours in advance. The company's technology aims to reduce preventable hospital deaths, morbidities, and the overall cost of care by enabling early intervention. Biocogniv has established partnerships with hospitals and healthcare systems to validate and implement its AI diagnostics, and they are focused on obtaining regulatory clearances to expand the adoption of their products. They have a strong team of data scientists, software engineers, and medical professionals. Biocogniv has also raised $6M in seed funding and has a strategic advisory board of industry leaders.